Lysine Deactylases: And then there were two

  1. Lorraine F Clark
  2. Thomas Kodadek  Is a corresponding author
  1. The Scripps Research Institute, United States

The addition of acetyl groups to lysine residues in proteins is an important step in a wide range of biological processes, including the regulation of gene expression, protein-protein interactions and protein stability (Beltrao et al., 2013; Zhang et al., 2009; Glozak et al., 2005; Kouzarides, 2000). The removal of these acetyl groups by enzymes called lysine deacetylases is also important (Downey and Baetz, 2015).

Two families of lysine deacetylases are known, and they both need a cofactor to be able to work properly (Yang and Seto, 2008). The only lysine deacetylase to have been identified in the bacterium Escherichia coli to date is called CobB, and it belongs to the family of enzymes that rely on a chemical called NAD+ as a cofactor (AbouElfetouh, et al., 2015). Now, in eLife, a team of researchers from China, Taiwan and the United States – including Shen Tu, Shu-Juan Guo and Chien-Sheng Chen as joint first authors – report that they have used a technique called “clip-chip” to identify a new lysine deacetylase in E. coli  (Tu et al., 2015).

In general, the clip-chip strategy uses two glass slides: one slide contains thousands of purified proteins, and the other is coated with a protein or molecule of interest. By placing the first slide onto top of the second, one can find out if any of the proteins on the first slide are enzymes that can use the protein of interest on the second slide as their substrate. Tu et al. tested thousands of proteins from E. coli against three different substrate slides. The three potential substrates were proteins that are acetylated heavily in E. coli cells, but are not deacetylated by CobB. They found that an E. coli protein called YcgC was a lysine deacetylase that has RutR – a protein that regulates transcription in E. coli – as a substrate. Further experiments revealed that, unlike other lysine deacetylases, YcgC does not require a cofactor. Tu et al. then used mass spectrometry techniques to find two specific lysine residues in RutR that are targeted by YcgC (Figure 1).

Regulation of gene transcription in E. coli by YcgC.

The acetylated form of the transcriptional regulator RutR enhances the expression of its target genes, such as pmrD and gcd (left). Tu et al. have discovered that YcgC can remove acetyl groups (COCH3; only the oxygen is shown in the figure) from at least two lysine residues on RutR (Lys52 and Lys62; middle). Moreover, deacetylation of RutR causes it to remove its own N-terminus. This deacetylated and truncated form of RutR represses the expression of pmrD and gcd (right). Further experiments showed that a serine called Ser200 (sidechain shown with OH) is crucial for YcgC’s catalytic activity.

Deacetylases belong to a broader class of enzymes called hydrolases, which use water molecules to break chemical bonds. By incubating purified YcgC with various chemicals that inhibit hydrolase enzymes, Tu et al. discovered that it belongs to the serine hydrolase family. This was confirmed by replacing the serine residues in YcgC and showing that the mutant enzyme was unable to deacetylate RutR in vitro.

Tu et al. went on to notice that RutR appeared to decrease in molecular weight after incubation with YcgC. Further investigation revealed that this decrease was caused by the removal of several residues from the N-terminal end of the RutR protein. Importantly, this did not occur if RutR proteins were unraveled by heat-treatment, which suggests that deacetylation causes the RutR protein to remove a short section from its N-terminal end in a process called autoproteolysis.

RutR represses gene expression, and further experiments showed that YcgC-mediated deacetylation of RutR led to reduced expression of at least two of its target genes. Further experiments revealed that YcgC regulates a set of substrates that are different to those regulated by CobB.

Tu et al. then searched for other bacterial proteins that looked like they may possess lysine deacetylase activity similar to that of YcgC. Several YcgC homologs were identified in several genera of bacteria, including Shigella and Yersinia. Furthermore, because YcgC and its homologs do not require NAD+ or zinc ions as a cofactor and look different from known bacterial lysine deacetylases, they likely represent a new family of lysine deacetylases.

Finally, we have become accustomed to thinking of lysine acetylation and deacetylation as driving reversible changes in the shape of proteins, with knock-on effects for protein-protein or protein-DNA interactions. However, as demonstrated by the fact that deacetylation leads to the removal of the N-terminus of RutR, this work reveals that they can also be coupled to irreversible protein modifications.

References

Article and author information

Author details

  1. Lorraine F Clark

    Departments of Chemistry and Cancer Biology, The Scripps Research Institute, Jupiter, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Thomas Kodadek

    Departments of Chemistry and Cancer Biology, The Scripps Research Institute, Jupiter, United States
    For correspondence
    kodadek@scripps.edu
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published:

Copyright

© 2015, Clark et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,156
    views
  • 106
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lorraine F Clark
  2. Thomas Kodadek
(2015)
Lysine Deactylases: And then there were two
eLife 4:e12724.
https://doi.org/10.7554/eLife.12724
  1. Further reading

Further reading

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Conor J Howard, Nathan S Abell ... Nathan B Lubock
    Research Article

    Deep Mutational Scanning (DMS) is an emerging method to systematically test the functional consequences of thousands of sequence changes to a protein target in a single experiment. Because of its utility in interpreting both human variant effects and protein structure-function relationships, it holds substantial promise to improve drug discovery and clinical development. However, applications in this domain require improved experimental and analytical methods. To address this need, we report novel DMS methods to precisely and quantitatively interrogate disease-relevant mechanisms, protein-ligand interactions, and assess predicted response to drug treatment. Using these methods, we performed a DMS of the melanocortin-4 receptor (MC4R), a G-protein-coupled receptor (GPCR) implicated in obesity and an active target of drug development efforts. We assessed the effects of >6600 single amino acid substitutions on MC4R’s function across 18 distinct experimental conditions, resulting in >20 million unique measurements. From this, we identified variants that have unique effects on MC4R-mediated Gαs- and Gαq-signaling pathways, which could be used to design drugs that selectively bias MC4R’s activity. We also identified pathogenic variants that are likely amenable to a corrector therapy. Finally, we functionally characterized structural relationships that distinguish the binding of peptide versus small molecule ligands, which could guide compound optimization. Collectively, these results demonstrate that DMS is a powerful method to empower drug discovery and development.

    1. Biochemistry and Chemical Biology
    Meina He, Yongxin Tao ... Wenli Chen
    Research Article

    Copper is an essential enzyme cofactor in bacteria, but excess copper is highly toxic. Bacteria can cope with copper stress by increasing copper resistance and initiating chemorepellent response. However, it remains unclear how bacteria coordinate chemotaxis and resistance to copper. By screening proteins that interacted with the chemotaxis kinase CheA, we identified a copper-binding repressor CsoR that interacted with CheA in Pseudomonas putida. CsoR interacted with the HPT (P1), Dimer (P3), and HATPase_c (P4) domains of CheA and inhibited CheA autophosphorylation, resulting in decreased chemotaxis. The copper-binding of CsoR weakened its interaction with CheA, which relieved the inhibition of chemotaxis by CsoR. In addition, CsoR bound to the promoter of copper-resistance genes to inhibit gene expression, and copper-binding released CsoR from the promoter, leading to increased gene expression and copper resistance. P. putida cells exhibited a chemorepellent response to copper in a CheA-dependent manner, and CsoR inhibited the chemorepellent response to copper. Besides, the CheA-CsoR interaction also existed in proteins from several other bacterial species. Our results revealed a mechanism by which bacteria coordinately regulated chemotaxis and resistance to copper by CsoR.